These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 12116045)

  • 1. Viral determinants and host immune responses in the pathogenesis of HBV infection.
    Rapicetta M; Ferrari C; Levrero M
    J Med Virol; 2002 Jul; 67(3):454-7. PubMed ID: 12116045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Action mechanism in immunopathogenesis and clearance of HBV].
    Im SJ; Sung YC
    Korean J Hepatol; 2006 Jun; 12(2):154-62. PubMed ID: 16804340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immune response induced by hepatitis B virus principal antigens.
    Huang CF; Lin SS; Ho YC; Chen FL; Yang CC
    Cell Mol Immunol; 2006 Apr; 3(2):97-106. PubMed ID: 16696896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunology of hepatitis B virus and hepatitis C virus infection.
    Rehermann B; Nascimbeni M
    Nat Rev Immunol; 2005 Mar; 5(3):215-29. PubMed ID: 15738952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variants of hepatitis B virus and their clinical relevance.
    Baumert TF; Barth H; Blum HE
    Minerva Gastroenterol Dietol; 2005 Mar; 51(1):95-108. PubMed ID: 15756149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The "metabolovirus" model of hepatitis B virus suggests nutritional therapy as an effective anti-viral weapon.
    Shlomai A; Shaul Y
    Med Hypotheses; 2008; 71(1):53-7. PubMed ID: 18334285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of the virus specific T-cell response in acute and chronic HBV and HCV infection].
    Panther E; Spangenberg HC; Neumann-Haefelin C; Rösler K; Blum HE; von Weizsäcker F; Thimme R
    Z Gastroenterol; 2004 Jan; 42(1):39-46. PubMed ID: 14997402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis viruses: live and let die.
    Herzer K; Sprinzl MF; Galle PR
    Liver Int; 2007 Apr; 27(3):293-301. PubMed ID: 17355449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B virus sensitizes hepatocytes to complement-dependent cytotoxicity through downregulating CD59.
    Qu Z; Liang X; Liu Y; Du J; Liu S; Sun W
    Mol Immunol; 2009 Dec; 47(2-3):283-9. PubMed ID: 19804910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small animal model systems for studying hepatitis B virus replication and pathogenesis.
    Dandri M; Lutgehetmann M; Volz T; Petersen J
    Semin Liver Dis; 2006 May; 26(2):181-91. PubMed ID: 16673296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B virus gene products as immunological targets in chronic infection.
    Feitelson MA
    Mol Biol Med; 1989 Oct; 6(5):367-93. PubMed ID: 2696858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lower serum viral loads in young patients with hepatitis-B-virus-related hepatocellular carcinoma.
    Tsai FC; Liu CJ; Chen CL; Chen PJ; Lai MY; Kao JH; Chen DS
    J Viral Hepat; 2007 Mar; 14(3):153-60. PubMed ID: 17305880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B virus X protein molecular functions and its role in virus life cycle and pathogenesis.
    Benhenda S; Cougot D; Buendia MA; Neuveut C
    Adv Cancer Res; 2009; 103():75-109. PubMed ID: 19854353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B.
    Zhang Z; Zhang JY; Wherry EJ; Jin B; Xu B; Zou ZS; Zhang SY; Li BS; Wang HF; Wu H; Lau GK; Fu YX; Wang FS
    Gastroenterology; 2008 Jun; 134(7):1938-49, 1949.e1-3. PubMed ID: 18455515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virus-host interaction in chronic hepatitis B virus infection.
    Thomas HC; Jacyna M; Waters J; Main J
    Semin Liver Dis; 1988 Nov; 8(4):342-9. PubMed ID: 3062789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ability of Hepatitis B surface antigen DNA vaccine to elicit cell-mediated immune responses, but not antibody responses, was affected by the deglysosylation of S antigen.
    Xing Y; Huang Z; Lin Y; Li J; Chou TH; Lu S; Wang S
    Vaccine; 2008 Sep; 26(40):5145-52. PubMed ID: 18462847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunopathology of hepatitis B virus infection.
    Tsai HT; Tsai TH; Lu TM; Yang CC
    Int Rev Immunol; 2008; 27(6):427-46. PubMed ID: 19065350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B virus DNA integration in hepatocellular carcinoma after interferon-induced disappearance of hepatitis C virus.
    Tamori A; Nishiguchi S; Shiomi S; Hayashi T; Kobayashi S; Habu D; Takeda T; Seki S; Hirohashi K; Tanaka H; Kubo S
    Am J Gastroenterol; 2005 Aug; 100(8):1748-53. PubMed ID: 16086711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Host immunity influences disease progression and antiviral efficacy in humans infected with hepatitis B virus.
    Wang FS; Zhang Z
    Expert Rev Gastroenterol Hepatol; 2009 Oct; 3(5):499-512. PubMed ID: 19817672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of hepatitis B virus infection through serological and virological markers.
    Kao JH
    Expert Rev Gastroenterol Hepatol; 2008 Aug; 2(4):553-62. PubMed ID: 19072403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.